Cargando…
Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
The discovery of new drugs for treating the new coronavirus (SARS-CoV-2) or repurposing those already in use for other viral infections is possible through understanding of the viral replication cycle and pathogenicity. This article highlights the advantage of targeting one of the non-structural pro...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IMSS. Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261434/ https://www.ncbi.nlm.nih.gov/pubmed/32536457 http://dx.doi.org/10.1016/j.arcmed.2020.05.024 |